Want to see IN:ZIMLAB full AI Analyst Report?
Zim Laboratories Ltd. (ZIMLAB) Income Statement
Zim Laboratories Ltd. Income Statement
Last quarter (Q1 2027), Zim Laboratories Ltd.'s total revenue was $941.78M, an increase of 31.25% from the same quarter last year. In Q1, Zim Laboratories Ltd.'s net income was $-40.17M. See Zim Laboratories Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 3.69B | $ 3.74B | $ 3.68B | $ 3.99B | $ 3.31B | |
| $ 616.36M | $ 730.04M | $ 1.86B | $ 903.81M | $ 1.67B | |
| $ 559.68M | $ 529.59M | $ 761.64M | $ 550.24M | $ 584.07M | |
| Depreciation and Amortization | $ 199.78M | $ 201.13M | $ 159.52M | $ 174.69M | $ 160.33M |
| $ 256.46M | $ 495.11M | $ 454.76M | $ 582.00M | $ 452.62M | |
| $ 56.68M | $ 200.46M | $ 1.10B | $ 310.82M | $ 224.56M | |
| $ 25.45M | $ -20.37M | $ -861.69M | $ 42.73M | $ -14.14M | |
| $ 82.13M | $ 180.09M | $ 236.42M | $ 353.55M | $ 210.43M | |
| $ 58.38M | $ 121.65M | $ 172.46M | $ 244.34M | $ 145.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.19 | $ 2.50 | $ 3.54 | $ 5.01 | $ 2.99 |
| Diluted EPS | $ 1.19 | $ 2.50 | $ 3.54 | $ 5.01 | $ 2.99 |
| Weighted Average Shares Outstanding | 49.06M | 48.66M | 48.72M | 48.73M | 48.73M |
| Weighted Average Shares Outstanding (Diluted) | 49.06M | 48.66M | 48.73M | 48.73M | 48.73M |
Currency in INR
